DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Shaverdian N, Lisberg AE, Bornazyan K. et al.
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 Phase 1 Trial.
Lancet Oncol 2017;
18: 895-903
DOI: 10.1016/S1470-2045(17)30380-7.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.